Sales & Marketing News | pharmaphorum

News

Person working at laptop with smartphone and coffee

Lawmakers seek answers on Pfizer, Lilly telehealth moves

US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth platforms could violate federal anti-kickback laws.

News

Starboard spells out its concerns with Pfizer's direction

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as

News

France warns of penalties if Opella production goes offshore

Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French governmen

News

AZ, Ionis get CHMP backing for ATTR polyneuropathy drug

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with transthyretin-mediated amyloidosis (ATTR), after the EMA's human medicines

News

Novo Nordisk closes on EU okay for haemophilia antibody

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.

News

PursueCare brings Pear addiction DTx apps back to life

Two pioneering digital therapeutics (DTx) for addiction are available once again after their original developer Pear Therapeutics was dissolved last year.

Lawmakers seek answers on Pfizer, Lilly telehealth moves

Starboard spells out its concerns with Pfizer's direction

France warns of penalties if Opella production goes offshore

AZ, Ionis get CHMP backing for ATTR polyneuropathy drug

Novo Nordisk closes on EU okay for haemophilia antibody

PursueCare brings Pear addiction DTx apps back to life

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks